Dolby Laboratories (DLB)
Quick ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 701,893 | 698,566 | 626,551 | 520,821 | 577,752 | 741,636 | 709,535 | 656,816 | 745,364 | 765,079 | 688,443 | 626,158 | 620,127 | 858,905 | 900,393 | 1,056,690 | 1,225,380 | 1,219,650 | 1,104,570 | 1,110,020 |
| Short-term investments | US$ in thousands | 703 | 763 | — | — | 0 | 127,321 | 115,863 | 140,823 | 139,148 | 124,210 | 126,393 | 132,875 | 189,213 | 156,812 | 141,688 | 80,618 | 38,839 | 48,277 | 58,582 | 52,261 |
| Receivables | US$ in thousands | 331,096 | 501,995 | 544,466 | 560,196 | 512,943 | 476,646 | 525,301 | 510,787 | 444,375 | 459,450 | 558,577 | 505,520 | 419,686 | 406,631 | 486,109 | 468,258 | 414,925 | 441,664 | 516,884 | 481,487 |
| Total current liabilities | US$ in thousands | 437,790 | 388,785 | 457,485 | 441,877 | 417,836 | 354,536 | 442,902 | 394,096 | 422,226 | 423,036 | 314,011 | 290,447 | 277,518 | 285,485 | 280,959 | 283,290 | 315,717 | 308,965 | 308,977 | 316,419 |
| Quick ratio | 2.36 | 3.09 | 2.56 | 2.45 | 2.61 | 3.80 | 3.05 | 3.32 | 3.15 | 3.19 | 4.37 | 4.35 | 4.43 | 4.98 | 5.44 | 5.67 | 5.32 | 5.53 | 5.44 | 5.19 |
September 30, 2025 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($701,893K
+ $703K
+ $331,096K)
÷ $437,790K
= 2.36
Peer comparison
Sep 30, 2025
Company name
Symbol
Quick ratio
Dolby Laboratories
DLB
2.36
ABM Industries Incorporated
ABM
1.35
Amentum Holdings Inc.
AMTM
1.24
Aramark Holdings
ARMK
0.80
Copart Inc
CPRT
8.13
Maximus Inc
MMS
1.46
Unifirst Corporation
UNF
1.70